The drugmaker may not pay Medicare beneficiaries’ out-of-pocket costs for a heart medication priced at $225,000 a year, a federal appeals court decided.
The drugmaker may not pay Medicare beneficiaries’ out-of-pocket costs for a heart medication priced at $225,000 a year, a federal appeals court decided.
Copyright © 2024 | WordPress Theme by MH Themes